Teeny Tiny Images: Nanoscopic Imaging And Hope For Multiple Sclerosis

DP
Day Pitney LLP

Contributor

Day Pitney LLP logo
Day Pitney LLP is a full-service law firm with more than 300 attorneys in Boston, Connecticut, Florida, New Jersey, New York and Washington, DC. The firm offers clients strong corporate and litigation practices, with experience on behalf of large national and international corporations as well as emerging and middle-market companies. With one of the largest individual clients practices on the East Coast, the firm also has extensive experience assisting individuals and their families, fiduciaries and tax-exempt entities plan for the future.
Chemical engineers at UC Santa Barbara have developed a new technique of nanoscopic imaging to study myelin sheaths, the membrane substance that coats nerves inside the brain and spinal chord.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Originally published on The Nano Newswire

Chemical engineers at UC Santa Barbara have developed a new technique of nanoscopic imaging to study myelin sheaths, the membrane substance that coats nerves inside the brain and spinal chord. This development could lead to new methods of detection and diagnosis for multiple sclerosis (MS) and other diseases.

Myelin sheaths act as transmission lines, enabling electrical signals to communicate. The "[m]yelin membranes are a class of biological membranes that are only two molecules thick, less than one millionth of a millimeter," said Jacob Israelachveli, one of the chemical engineers involved. MS, a demyelinating disease, is characterized by lesions that appear in the myelin resulting in the disintegration of the myelin sheath. According to the National Multiple Sclerosis Society, about 400,000 Americans and 2.5 million people worldwide suffer from MS.

The researchers utilized fluorescent imaging at the nanoscopic level to study domains – clusters of lipid molecules that make up myelin membranes. The study, published in Proceedings of the National Academy of Sciences, reports that researchers noted differences in the appearance, size, and sensitivity to pressures between healthy and diseased clusters of lipid molecules. As explained by Israelachveli "[t]he discovery and characterization of micron-sized domains that are different in healthy and diseased lipid assemblies have important implications for the way these membranes interact with each other. And this leads to new understanding of demyelination at the molecular level."

These findings will help pave the way for new methods of detection, diagnosis, and possible treatment of MS.

www.daypitney.com

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More